Elisabetta Faenza

CEO and Co-Founder, LeafCann Group


Born with a rare congenital disorder, Elisabetta’s parents were told by doctors that she would never reach adulthood. Beating the odds, Elisabetta has been driven by a goal to demystify and find treatments for rare conditions through a dedication to research and discovery. Elisabetta brings a life-time of experience working with plant-based medicines, environmental agriculture and her very personal commitment to precision medicine to everything she does in her role as CEO of LeafCann Group and the advancement of medicinal cannabis in the 21st Century.

What You Need To Know: Regulatory update and new opportunities for the medicinal cannabis industry
Back to program
Back to Speakers


LeafCann’s mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production and GMP manufacturing.
Read more
Join Us!

Register your interest to attend and stay up to date with our latest news.